<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03664609</url>
  </required_header>
  <id_info>
    <org_study_id>A4170</org_study_id>
    <nct_id>NCT03664609</nct_id>
  </id_info>
  <brief_title>Deep Brain Stimulation (DBS) Retrospective Outcomes Study</brief_title>
  <official_title>Deep Brain Stimulation (DBS) Retrospective Outcomes Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to characterize real-world clinical outcomes of Deep
      Brain Stimulation (DBS) using retrospective review of de-identified patient records.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to characterize

      1. real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of
      de-identified patient records.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 12, 2019</start_date>
  <completion_date type="Anticipated">June 29, 2028</completion_date>
  <primary_completion_date type="Anticipated">June 29, 2028</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Change in Unified Parkinson's Disease Rating Scale (UPDRS III) at up to 5 years post implant compared to baseline</measure>
    <time_frame>5 yrs. post implant</time_frame>
    <description>Improvement in disease symptoms as assessed by Unified Parkinson's Disease Rating Scale (UPDRS III) at up to 5 years post implant compared to baseline</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Parkinson Disease</condition>
  <condition>Essential Tremor</condition>
  <condition>Dystonia</condition>
  <arm_group>
    <arm_group_label>Parkinson's Disease</arm_group_label>
    <description>Subjects with Parkinson's disease, implanted with a Boston Scientific Deep Brain Stimulation System</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Essential Tremor</arm_group_label>
    <description>Subjects with Essential Tremor, implanted with a Boston Scientific Deep Brain Stimulation System</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dystonia</arm_group_label>
    <description>Subjects with dystonia, implanted with a Boston Scientific Deep Brain Stimulation System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Deep Brain Stimulation</intervention_name>
    <description>Deep Brain Stimulation in patients with Parkinson Disease, Dystonia and Essential Tremor.</description>
    <arm_group_label>Dystonia</arm_group_label>
    <arm_group_label>Essential Tremor</arm_group_label>
    <arm_group_label>Parkinson's Disease</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects' chart data will be drawn from the Investigator's standard patient pool treated at
        his/her practice.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be previously treated with or eligible for implantation with a deep brain
             stimulation system

        Exclusion Criteria:

          -  No Exclusion Criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roshini Jain</last_name>
    <role>Study Director</role>
    <affiliation>Boston Scientific Neuromodulation Corporation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diane Keesey</last_name>
    <phone>661-949-4175</phone>
    <email>diane.keesey@bsci.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Roshini Jain</last_name>
    <phone>469-766-9888</phone>
    <email>roshini.jain@bsci.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Boston Scientific Clinical Research Information Toll Free Number</name>
      <address>
        <city>Valencia</city>
        <state>California</state>
        <zip>91355</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>August 31, 2018</study_first_submitted>
  <study_first_submitted_qc>September 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 10, 2018</study_first_posted>
  <last_update_submitted>April 7, 2020</last_update_submitted>
  <last_update_submitted_qc>April 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Dystonia</mesh_term>
    <mesh_term>Essential Tremor</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

